|
1
|
de Lima Silva N, Nobre D, Alves de Oliveira J, Santos Rezende M, da Conceição dos Santos JT, de Souza Araújo AA, Quintans-Júnior LJ, Marques Cavalcante RC, de Souza Ferreira LC, Martins-Filho PR, Schimieguel DM. Kinetics of humoral immune response in patients with asymptomatic or mild COVID-19: a longitudinal study based in an in-house indirect ELISA method. EXCLI J 2022; 21:1167-1170. [PMID: 36381645 PMCID: PMC9650694 DOI: 10.17179/excli2022-5337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Accepted: 08/23/2022] [Indexed: 01/24/2023]
Affiliation(s)
- Nathanielly de Lima Silva
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil
| | - Danilo Nobre
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | - Joyceane Alves de Oliveira
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil
| | - Márcia Santos Rezende
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil
| | - Joyce Thayane da Conceição dos Santos
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil
| | - Adriano Antunes de Souza Araújo
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil,Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil
| | - Lucindo José Quintans-Júnior
- Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil,Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil,Laboratory of Neuroscience and Pharmacological Assays (LANEF), Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | | | | | | | - Dulce Marta Schimieguel
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil,Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil,*To whom correspondence should be addressed: Dulce Marta Schimieguel, Departamento de Farmácia, Laboratório de Hematologia, Universidade Federal de Sergipe, São Cristóvão, Sergipe, Brasil, CEP: 49100-000, E-mail:
| |
Collapse
|
|
2
|
Pinheiro LHS, Trindade LD, Costa FDO, Silva NDL, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, da Cruz GS, de Lyra Junior DP, Schimieguel DM. Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis. Int J Hematol Oncol Stem Cell Res 2020; 14:274-288. [PMID: 33603989 PMCID: PMC7876425 DOI: 10.18502/ijhoscr.v14i4.4484] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
Background: The aim of this review was to evaluate the influence of aberrant phenotypes in prognosis and survival in acute myeloid leukemia (AML) patients by multiparametric flow cytometry. Materials and Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a review of PubMed, Scopus, Science Direct and Web of Science was carried out through 1998 to 2016, conducted by two reviewers independently, evaluating titles, abstracts and full-texts of the selected studies. Results: Ten studies were included on this review, in which the aberrant phenotype expression of 17 markers were detected in AML patients. From these, 11 aberrant phenotypes were associated with prognosis, which eight had shown negative impact on prognosis: CD7, CD56, CD15, CD2, CD3, CD90low, CD123high, CD117high, and three others were associated with good prognosis: CD19, CD98high and CD117+/CD15+. Meta-analysis showed that aberrant expression of CD56 as a poor prognostic marker with unfavorable outcomes is implicated in decreased overall survival in AML patients in 28 months (95% CI: 0.62 to 0.92). Conclusion: This was observed when there was association between CD56 expression and other prognostic factors, influencing on patients’ management care and treatment.
Collapse
Affiliation(s)
| | - Louise Dantas Trindade
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | | | - Nathanielly de Lima Silva
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | - Alex Freire Sandes
- Department of Medicine, Hematology Course, Federal University of São Paulo, São Paulo, São Paulo, Brazil
| | | | - Cristiane Bani Correa
- Department of Morphology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | | | | | | | - Dulce Marta Schimieguel
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| |
Collapse
|